Diana Cîrstea is a distinguished medical oncologist and research fellow specializing in hematologic malignancies and stem cell transplant at Dana-Farber Cancer Institute and Brigham and Women's Hospital in Boston, MA. She also serves as an instructor at Harvard Medical School and is affiliated with Massachusetts General Hospital. Born and educated in Moldova, Diana earned her M.D. from the Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu.”Diana's research is focused on multiple myeloma, where she has contributed significantly to the understanding and development of novel therapeutic strategies. Her work includes pivotal studies on the regulation of sclerostin expression, the efficacy of selective HSP90α/β inhibitors, and the potential of dual TORC1/2 inhibitors. Her publications, such as those in high-impact journals like Blood, Leukemia, and J Bone Miner Res, underscore her role as a leading scientist in oncology research.Recognized among the Top 100 Women Scientists, Diana maintains an active presence on social media platforms like Facebook and Instagram, engaging with both the medical community and the public. Her career is marked by a deep commitment to improving patient outcomes through research and clinical excellence, making her a prominent figure in the fight against cancer.